INTRODUCTION {#S1}
============

DNA methylation in mammals refers to the modification of cytosine by the addition of a methyl group, usually at the CpG dinucleotide. Because methylcytosine spontaneously deaminates at very high frequency, methylated cytosines are lost from the germline genome ([@R43]; [@R45]), resulting in under-representation except at CpG islands (CGIs). These are normally unmethylated and under strong selective pressure to remain so. CGIs are sometimes classed as 'weak' or 'strong', depending on the CpG density and are frequently associated with the transcriptional start sites of genes ([@R5]). Classically, CGIs have been identified by bioinformatic means but, more recently, biochemical assays based on binding of the CXXC domain protein CFP1 have been used to identify CGIs conserved between mouse and human, almost half of which were not detected bioinformatically. Many CFP1-defined CGIs are located away from annotated promoters in intra- or intergenic locations, and have been termed 'orphan' CGIs ([@R17]).

Although genome-wide sequencing approaches have increased our knowledge of when and where methylation occurs, relatively few classes of genes have been demonstrated to be functionally regulated by methylation. One group of developmentally important genes demonstrably controlled by methylation consists of imprinted genes ([@R1]). These are associated with gametic differentially methylated regions (gDMRs), which show different levels of methylation in sperm and egg, driven by the activity of the *de novo* enzyme DNA methyltransferase 3A (DNMT3A) and the essential co-factor DNMT3L ([@R36]), but with a possible small contribution from DNMT3B in sperm ([@R18]). Loss of differential methylation causes changes in transcription at the imprinted genes. Methylation of imprinted gDMRs largely occurs (19/22 gDMRs) in the oocyte ([@R35]; [@R33]).

Methylation patterns differ globally between the gametes, not just at imprinted regions, and many non-imprinted loci have recently been shown to have gDMRs ([@R21]; [@R39]). Following fertilisation, almost total erasure occurs on the paternally inherited chromosomes however, probably mediated by TET3 ([@R10]). For maternal chromosomes too there is a passive loss of methylation by dilution, until it reaches a minimum at the blastocyst stage. Following implantation *de novo* methylation occurs, primarily driven by DNMT3B ([@R2]). DNMT3 family members are barely detectable in most adult tissues except testis and thymus, although DNMT3A is also found in brain ([@R32]; [@R49]; [@R50]). Thus, propagation of methylation patterns is thought to be reliant on the ubiquitous maintenance enzyme DNMT1 ([@R14]; [@R22]), although DNMT3A/B may also play a role in embryonic stem cells (ESCs) ([@R3]).

Despite some recent studies looking at loci inheriting methylation from the mother ([@R2]; [@R39]; [@R21]), a number of questions remain unresolved. In particular, we aimed to: (1) determine if there are any gene classes that are over-represented in these ∼1000 oocyte-specific gDMRs; (2) determine the functional significance of methylation at these loci by removing it and examining the transcriptional response; (3) examine the conservation of any gDMR between human and mouse; (4) determine the methyltransferases important for establishment and maintenance of the gDMR; and (5) compare the gDMR properties with those of imprinted loci.

We show here that there are three distinct types of oocyte gDMR: those associated with imprinted genes and then two transient gDMR classes, one containing genes associated with testis function and the other with brain function. The former appear to be marked at the promoter by DNA methylation, helping to suppress transcription. The brain-specific genes are instead methylated intragenically. Postfertilisation, both testis and brain gDMRs become fully methylated by *de novo* methylation of the paternal allele. Testis-specific genes require methylation for complete repression, and in its absence they become upregulated by several orders of magnitude. Unlike imprinted genes, neither of the non-imprinted gDMR classes requires germline passage to re-establish methylation.

RESULTS {#S2}
=======

Identification of genes that resemble imprinted genes in their methylation ontogeny {#S3}
-----------------------------------------------------------------------------------

We reanalysed recently published ([@R21]; [@R39]) datasets looking for CGIs that: (1) were completely methylated (\>75%) in wild-type (WT) meiosis II (MII) oocytes; (2) were significantly methylated in blastocysts; and (3) lost \>50% methylation in DNMT3L-deficient oocytes. The threshold for significant methylation in blastocysts was set to 25%, based on the fact that many imprinted CGIs show methylation at ∼30% in the genome-wide analyses. In the first of these studies, which used reduced representation bisulfite sequencing (RRBS) of oocytes in MII, 2146 /23,019 CGIs examined were \>75% methylated in oocyte: after removing intergenic CGIs and accounting for multiple CGIs associated with a single gene, this gave 897 RefSeq-annotated genes with at least one completely methylated CGI ([Fig. 1A](#F1){ref-type="fig"}). None of these was methylated in sperm. In blastocyst, only 529 genes had CGIs with significant methylation ([Fig. 1A](#F1){ref-type="fig"}). Interestingly, most genes (421/529, 80%) that were methylated at this level in blastocyst were also methylated in oocyte, and more heavily methylated in oocyte than in sperm, indicating that they are oocyte gametic differentially methylated regions (oocyte gDMRs). Although we distinguish ([Fig. 1A](#F1){ref-type="fig"}) between CGIs that appear to gain methylation preimplantation (108/529) and those that retain methylation from the oocyte (421/529), it is possible that some in the latter group are both demethylated early on and then remethylated to a lower degree on both alleles. In contrast to the oocyte CGIs, only 12 sperm gDMRs showed retention of methylation in the blastocyst. Indicating the importance of DNMT3L, 91% (382/421) of the genes methylated in both oocyte and blastocyst lost \>50% of their methylation in oocytes from *Dnmt3l*^-/-^ females ([Fig. 1A](#F1){ref-type="fig"}).

![**Two novel gene classes with gametic differentially methylated regions (gDMRs).** (A) Numbers of genes (*n*) showing methylation (Meth) in oocyte, blastocyst or both from reanalysis of published genome-wide data ([@R39]). DNMT3L-dependent: genes with \>50% loss of methylation in DNMT3L-deficient oocytes. (B) Top-ranking classes of genes by ontology analysis of data from: (i) reduced representation bisulfite sequencing (RRBS) in meiosis II (MII) oocytes (as in A); (ii) whole bisulfitome amplified DNA sequencing on germinal vesicle (GV) oocytes \[WBA-seq ([@R21])\]; and (iii) methylated DNA immunoprecipitation (meDIP) on preimplantation embryos ([@R2]). *P*-value and false discovery rate (FDR) are indicated. (C) Top-scoring class from B(i) compared with novel imprinted genes ([@R6]) and those identified by meDIP \[B(iii)\]. (D) Methylation ontogeny of representative groups of genes from each gDMR class; genes methylated postimplantation are also shown as a control. 3L KO, oocytes from *Dnmt3l*^-/-^ females; Blast, blastocyst. Error bars represent s.e.m. (E) Structure of prototypical brain (*Crocc*) and testis (*Rhox13*) gDMR genes. Black boxes: CpG islands (CGIs), with ID number, identified by CFP1 binding ([@R17]). Green boxes: CGI identified by conventional means, with number of CpGs indicated. Pyro, region covered by pyrosequencing assay. (F) Proportions of brain gDMRs at known (RefSeq) transcriptional start sites (TSSs), those showing TSS-associated chromatin marks in ESCs or brain cells, and those with no evidence of being TSSs.](DEV104646F1){#F1}

To determine whether any gene class was over-represented in this group (*n*=382) of DNMT3L-dependent oocyte gDMR genes, we used the functional annotation clustering tool on the DAVID platform ([@R16]). The top-scoring groups of genes identified as being enriched are indicated in [Fig. 1Bi](#F1){ref-type="fig"}. This identified genes associated with the term 'brain', such as *Crocc, Grin3b* and *Adcy6* (total *n*=199), as markedly over-represented (*P*=5.76×10^-11^), accounting for 52% of the total group: indeed, 4/5 top classes were central nervous system genes ([Fig. 1Bi](#F1){ref-type="fig"}). DAVID analysis of the genes methylated in blastocyst (*n*=529) gave very similar results. Analysis of an independent dataset derived from whole bisulfitome DNA amplification-sequencing (WBA-seq) on germinal vesicle (GV) stage oocytes ([@R21]) was a close match, with identity in 4/5 classes and similar ranking despite the different approaches, stage of maturity and numbers of CGIs examined ([Fig. 1Bii](#F1){ref-type="fig"}). By contrast, a study by Weber and colleagues employing methylated DNA immunoprecipitation (meDIP) ([@R2]) found that the class of genes most significantly associated (*P*=5.6×10^-5^) with preimplantation methylation was the testis-specific genes ([Fig. 1Biii](#F1){ref-type="fig"}) and that some of these were oocyte gDMRs. This is likely to be due in part to differences in technique, since only promoter regions were examined in the meDIP study, and many of the testis genes had non-CGI promoters and thus were under-represented in the other studies. Examination of the WGA-seq analysis, however, also indicated that many testis-specific genes were methylated in oocyte ([@R21]), despite not being highlighted by ontogeny analysis. Re-inspection confirmed that testis-specific genes, such as *Dpep3, Piwil1, Fkbp6, Rhox13, Trim52, Spag1, Ggn1, Tbpl1, Spata16, Csnka2ip* and *Tssk2*, identified in these two latter studies, do fulfil our criteria for DNMT3L-mediated programming. Notably, the testis-specific genes showed no overlap with the group of germline genes that are methylated postimplantation by DNMT3B, such as *Dazl, Sycp3* and *Tex12*, identified earlier ([@R2]; [@R11]; [@R26]; [@R45]). The latter group is completely unmethylated in oocyte and blastocyst, unlike the testis gDMR genes, is independent of DNMT3L status but dependent on DNMT3B and contains genes expressed in oocyte as well as testis (e.g. the Sycp genes).

The top-scoring class from our DAVID analyses includes a few known imprinted genes expressed in brain (e.g. *Snrpn, Gnas* and *Ncdn*, which were excluded from this group in later analyses), suggesting the presence of novel imprinted genes. Many new brain-specific imprinted genes were recently reported from genome-wide analyses ([@R8]; [@R9]), although only a fraction have been independently validated ([@R6]). Likewise, some of the testis-specific genes show allele-specific methylation preimplantation ([@R2]), a feature of imprinted genes. [Fig. 1C](#F1){ref-type="fig"} shows little overlap, however, between the genes identified in those studies and the brain genes identified in the RRBS dataset. Of the novel brain-specific imprinted genes identified by others, only three (*Ccdc40, Cdh15* and *Herc3*; [Fig. 1C](#F1){ref-type="fig"}) also have a DNMT3L-dependent gDMR: significantly, these are among the minority that have been experimentally validated ([@R6]; [@R8]; [@R33]). Our analysis therefore suggested that there might be three classes of DNMT3L-programmed gDMR: those associated with imprinted genes, genes important for brain function and genes that are specific to the testis.

[Fig. 1D](#F1){ref-type="fig"} tracks the methylation ontogeny of each of the three classes, as well as the germline genes methylated postimplantation, based on approximately equal numbers of genes representative of each class for which data are available from more than one study. All three gDMR groups show strong dependence on DNMT3L in oocyte, lower methylation in sperm and retention of methylation in blastocyst ([Fig. 1D](#F1){ref-type="fig"}). By contrast, the postimplantation group shows no methylation at any of these stages. The brain gDMR displays higher methylation in sperm and greater variability overall than the other two groups ([Fig. 1D](#F1){ref-type="fig"}). The CGI structure and location also differ between groups. The gDMRs of the testis genes are: (1) generally the only CGI present; (2) classical CGIs; and (3) always located at the proximal promoter position upstream of the first exon (e.g. *Rhox13*; [Fig. 1E](#F1){ref-type="fig"}). By contrast, the brain gene had: (1) multiple CGIs; (2) gDMRs that were always intragenic CGIs, usually in an exon; (3) gDMRs that were non-classical or orphan CGIs, as defined by CFP1 binding; and (4) an unmethylated promoter CGI (e.g. *Crocc* CGI 4-1220; [Fig. 1E](#F1){ref-type="fig"}). Confirming that brain gDMRs are largely intragenic rather than promoter associated, only 14% (21/151) of brain gDMRs common to both the RRBS and WGA-seq studies were at annotated RefSeq transcription start sites (TSSs) ([Fig. 1F](#F1){ref-type="fig"}). Furthermore, only 18% (23/130) of the remainder were enriched for hypophosphorylated RNA polymerase II and H3K4me3, indicative of TSSs ([@R17]), in mouse ESCs: in brain tissues this number fell to 11% (14/130). The imprinted regions are more diverse but, as previously noted ([@R4]), the gDMR is generally one of multiple CGIs at these loci and tends to be intragenic. These results identify three distinct classes of gDMR programmed by DNMT3L in the mouse oocyte.

*Dnmt3l* is required for methylation and repression of some testis genes in the female germline {#S4}
-----------------------------------------------------------------------------------------------

We set about validating these bioinformatic data by collecting oocytes from 22 days postpartum (22 dpp) WT and *Dnmt3l^-/-^* mice. Using combined bisulfite treatment and restriction analysis (COBRA), which produces digested bands only if a region is methylated, we first confirmed the known DNMT3L-dependent methylation of the gDMR at *Snrpn*, as a control, using oocytes from WT and *Dnmt3l*^-/-^ females ([Fig. 2A](#F2){ref-type="fig"}). *H19* shows no methylation, confirming the lack of somatic cell contamination ([Fig. 2A](#F2){ref-type="fig"}). The testis gDMR at *Dpep3* and *Piwil1*, previously identified by meDIP ([@R2]), also showed near-complete methylation in WT oocytes, further confirmed by clonal analysis ([Fig. 2A,B](#F2){ref-type="fig"}). The weak CGI at *Csnka2ip*, however, only showed partial methylation in oocyte ([Fig. 2A,B](#F2){ref-type="fig"}). Sperm methylation was seen only at the control locus *H19* ([Fig. 2A](#F2){ref-type="fig"}). The gDMRs all showed total loss of methylation in oocytes from *Dnmt3l^-/-^* females ([Fig. 2A](#F2){ref-type="fig"}), as confirmed by bisulfite sequencing (examples in [Fig. 2B](#F2){ref-type="fig"}). Two further testis-specific genes, *Rhox13* and *Fkbp6*, identified by RRBS ([@R39]), were also highly methylated in oocyte, whereas *Dazl*, which is methylated postimplantation by DNMT3B ([@R45]), was not ([Fig. 2C](#F2){ref-type="fig"}). Methylation at *Fkbp6* in sperm ([Fig. 2C](#F2){ref-type="fig"}) is in contrast to earlier reports, but was confirmed by clonal analysis ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.104646/-/DC1) Fig. S1). *Fkbp6* is transcribed in spermatogonial stem cells ([Fig. 2D](#F2){ref-type="fig"}) but is switched off and presumably methylated as cells enter meiosis. By contrast, *Ddx4*, which belongs to the postimplantation group, is transcribed in postmeiotic spermatocytes (white arrowhead, [Fig. 2D](#F2){ref-type="fig"}) and not methylated in sperm.

![**Validation of methylation at novel gDMRs in gametes and effects of DNMT3L loss.** (A) COBRA of methylation in wild-type (WT) and DNMT3L-deficient (3L) mouse oocytes. un, uncut; u, unmethylated; asterisk, limit digest band. (B) Clonal analysis, with methylation as a percentage of all sites indicated. Arrowheads indicate sites also analysed by COBRA. (C) As for A. Post-impl, genes known to be methylated only after implantation. (D) *In situ* hybridisation of testis tissue. Arrow indicates spermatogonial stem cells; arrowhead indicates spermatozoa. (E) Methylation of gDMRs as detected by pyrosequencing in sperm and oocytes. (F) RT-qPCR showing transcript levels in WT and 3L KO ovaries for the indicated genes. Error bars indicate s.e.m. ^\*\*^*P*\<0.01, ^\*\*\*^*P*\<0.001 by *t*-test.](DEV104646F2){#F2}

We used pyrosequencing, a more quantitative method, to extend our studies to brain gDMRs, as these show smaller differences in methylation between sperm and oocyte ([Fig. 1D](#F1){ref-type="fig"}). This assay gave similar results to previous COBRA and clonal analyses for imprinted (*Peg1*) and testis-specific (*Rhox13*) loci and confirmed that intragenic gDMRs at brain-specific genes such as *Grin3b, Adcy6* and *Crocc* show significantly different methylation between oocytes and sperm ([Fig. 2E](#F2){ref-type="fig"}).

In order to determine if demethylation of any of these sequences results in transcriptional activation, we examined mRNA levels in ovary by reverse-transcription quantitative PCR (RT-qPCR). This showed a small but significant upregulation of *Dpep3* and *Piwil1* in DNMT3L-deficient ovaries ([Fig. 2F](#F2){ref-type="fig"}), the latter supporting a previous observation ([@R21]). By contrast, *IAP* was not derepressed in this tissue ([Fig. 2F](#F2){ref-type="fig"}), despite showing levels of methylation in *Dnmt3l*^-/-^ oocytes as low as those seen in primordial germ cells, where they reach their minimum ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.104646/-/DC1) Fig. S2). As the brain gDMRs are not at promoters, they were not assessed. These results validate the bioinformatic analysis above and suggest a role for methylation in maintaining suppression at some non-imprinted loci in oocyte.

Brain and testis gDMRs become fully methylated postimplantation, with methylation required for suppression of testis genes {#S5}
--------------------------------------------------------------------------------------------------------------------------

When we looked at postimplantation tissues, the *Snrpn* gDMR, as expected for an imprinted gene, retained ∼50% methylation in adult somatic tissues ([Fig. 3A](#F3){ref-type="fig"}). By contrast, all of the testis gDMRs showed complete or near-complete methylation ([Fig. 3A](#F3){ref-type="fig"}), indicating a gain of methylation on the paternal allele. Methylation levels were comparable to those seen at *Sycp3* ([Fig. 3A](#F3){ref-type="fig"}), part of the group methylated postimplantation by DNMT3B ([@R45]). Pyrosequencing confirmed these results and extended them to brain gDMRs, which also showed near-complete methylation in adult tissues ([Fig. 3B](#F3){ref-type="fig"}), indicating that the brain and testis gDMRs show transient, rather than stable, differential methylation. The similar levels of methylation in tissues derived from all three germ layers indicate establishment early postimplantation.

![**Methylation and repression at novel gDMRs in adult mouse tissues.** (A) COBRA on the adult mouse tissues and cell lines indicated at the top. Fibro, fibroblasts without (-) or with (+aza) 5-aza-2′-deoxycytidine. (B) Methylation analysis by pyroassay. (C) All analysed genes showed significant demethylation (*P*\<0.05, ANOVA) by pyroassay following Aza treatment. (D) RT-PCR for the indicated genes in treated fibroblasts. Testis is a positive control (Pos ctrl), except for *Adcy6* and *Grin3b*, where brain was used. *IAP* and *Sycp3* are known to be repressed by methylation. Asterisked genes have low-density CGIs. *Hprt* is a loading control. (E) RT-qPCR of samples from D. UT, untreated. Error bars indicate s.e.m.](DEV104646F3){#F3}

Although such high methylation is inconsistent with imprinting, it could still be important for transcriptional repression. NIH 3T3 fibroblast cells showed levels of DNA methylation comparable to primary tissues for most of the genes of interest ([Fig. 3A](#F3){ref-type="fig"}, lanes at right); treatment with the methyltransferase inhibitor 5-aza-2′-deoxycytidine (Aza) caused demethylation ([Fig. 3A,C](#F3){ref-type="fig"}) and strong induction ([Fig. 3D](#F3){ref-type="fig"}) of *Sycp3* and *IAP* as expected ([@R2]; [@R44]). All testis gDMRs showed substantial demethylation by COBRA ([Fig. 3A](#F3){ref-type="fig"}) and pyroassay ([Fig. 3C](#F3){ref-type="fig"}; *P*\<0.05 for all genes) and were strongly induced ([Fig. 3D](#F3){ref-type="fig"}) from almost undetectable levels in untreated fibroblasts. Extension of this analysis to cover additional testis gDMRs by RT-qPCR showed substantial derepression at some other loci (*Rhox9, Trim52, Spata16*; [Fig. 3E](#F3){ref-type="fig"}). There was a notable gradation of response dependent on CpG density in the gDMR: out of three testis genes containing weak CGIs (*Tssk2, Csnka2ip, Dnmt3l*), only one (*Dnmt3l*) showed significant (*P*=0.04) derepression ([Fig. 3D,E](#F3){ref-type="fig"}); this effect on *Dnmt3l* is consistent with previous reports by ourselves and others ([@R15]; [@R29]). By contrast, many of the brain gDMR genes were less heavily repressed in fibroblasts and showed substantial baseline transcription by RT-PCR, using brain as a positive control ([Fig. 3D](#F3){ref-type="fig"}). Consistent with brain gDMRs not being cryptic promoters, Aza treatment gave demethylation (all *P*\<0.05) but no significant derepression, except for a slight (*P*=0.036) effect at *Adcy6* ([Fig. 3D,E](#F3){ref-type="fig"}). These results show a postimplantation gain of methylation on the paternal allele at brain and testis gDMRs and an important role for methylation in maintaining suppression of the latter.

Conservation of methylation and repression in a human cell line {#S6}
---------------------------------------------------------------

We extended our study to hTERT-1604 immortalised human fibroblasts, which have previously been shown to retain normal methylation at many loci ([@R25]). Methylation at the *SNRPN* locus is within the 40-60% range ([Fig. 4A](#F4){ref-type="fig"}) normal for imprinted gDMRs ([@R48]). The testis-specific genes *DPEP3, PIWIL1* and *FKBP6* showed high levels of conservation between mouse and human, retained their promoter CGIs and were heavily methylated ([Fig. 4A](#F4){ref-type="fig"}). *SYCP3* and *DAZL* were also heavily methylated as expected, and are shown as controls ([Fig. 4A](#F4){ref-type="fig"}). Many brain genes also showed conservation of the intragenic CGI that constitutes the murine gDMR. Methylation was \>75% for *GRIN3B* and *ADCY6*, as seen in mouse, although *EFNA* was not heavily methylated in this cell line ([Fig. 4A](#F4){ref-type="fig"}).

![**Conservation of methylation and repression in human.** (A) Methylation levels as determined by pyrosequencing in hTERT-1604 normal human fibroblasts. (B) RT-PCR showing derepression by Aza treatment (lane +) is comparable between testis gDMR genes (left) and genes methylated postimplantation (right). Adult testis is a positive control; *ACTB* is for loading. (C) Significant differences in methylation were seen at all analysed genes in cells exposed to Aza or depleted of DNMT1 by siRNA (*P*\<0.05, except for *FKBP6* with Aza which was not significant). (D) RT-qPCR for the same samples. All upregulation \>5-fold was significant at *P*\<0.05. Error bars indicate s.e.m.](DEV104646F4){#F4}

Contrasting with robust signal in testis, little or no transcription from the testis gDMR group (*DPEP3, FKBP6, PIWIL1*) or from the genes methylated postimplantation (*SYCP3, SYCP1, DAZL, TEX12*) could be detected in untreated hTERT-1604 fibroblasts, as expected ([Fig. 4B](#F4){ref-type="fig"}). Humans lack a *Rhox13* homologue, but *RHOXF1*, which is related to the ancestral gene in mice, also showed the same expression pattern ([Fig. 4B](#F4){ref-type="fig"}). On treatment with Aza, all of the testis loci except *FKBP6* showed significant demethylation (*P*\<0.05; Aza, [Fig. 4C](#F4){ref-type="fig"}), although it is notable that the gDMR appeared to be more resistant (loss \<10%) than the postimplantation genes (loss \>15%). All genes except *PIWIL1* were reliably upregulated ([Fig. 4B](#F4){ref-type="fig"}) and RT-qPCR confirmed major differences in transcript levels versus control (*P*\<0.05; [Fig. 4D](#F4){ref-type="fig"}). Brain genes showed low-level transcription in fibroblasts and failed to show substantial upregulation with Aza (not shown), as found in mouse ([Fig. 3D](#F3){ref-type="fig"}). Aza affects all three methyltransferases as well as having some non-specific effects, so we also carried out siRNA knockdown for *DNMT1* and collected RNA at day 4. Significant (*P*\<0.05) demethylation at all the testis and postimplantation loci examined (siRNA, [Fig. 4C](#F4){ref-type="fig"}) correlated with upregulation of *FKBP6, SYCP3* and *DAZL* ([Fig. 4D](#F4){ref-type="fig"}). These results confirm that methylation plays an evolutionarily conserved role in regulating testis genes identified as gDMR in mice, as well as germline genes methylated postimplantation.

Contribution of DNMT1 versus DNMT3A/B to maintenance methylation of gDMRs {#S7}
-------------------------------------------------------------------------

We used knockout (KO) ESC lines to assess the dependence of non-imprinted gDMRs on the maintenance versus *de novo* enzymes for perpetuation of methylation. Parental J1 ESCs retain appropriate methylation at the *Snrpn, H19* and *Peg1* gDMRs by COBRA ([Fig. 5A](#F5){ref-type="fig"}) and/or pyrosequencing ([Fig. 5D](#F5){ref-type="fig"}), and clonal analysis showed that *Snrpn* predominantly displays the two patterns typical of imprinted genes, either fully methylated or fully unmethylated ([Fig. 5B](#F5){ref-type="fig"}). J1 ESCs lacking a functional *Dnmt1* gene also showed methylation loss at the imprinted loci, as expected (1KO, [Fig. 5A,D](#F5){ref-type="fig"}). Whereas all of the testis gDMRs showed levels of methylation comparable to (*Piwil1, Rhox13, Fkbp6*) or greater than (*Dpep3, Csnka2ip*) in blastocyst, they showed clear loss of methylation in DNMT1 KO cells by COBRA ([Fig. 5A](#F5){ref-type="fig"}) and significant demethylation by pyroassay; *Rhox13* is shown as an example ([Fig. 5D](#F5){ref-type="fig"}; WT versus 1KO, *P*=0.002). The same was true for brain gDMRs, as assessed by pyroassay ([Fig. 5D](#F5){ref-type="fig"}; all *P*\<0.05). Interestingly, although *Fkbp6*, like *Snrpn*, shows ∼50% methylation overall there is less clear partitioning of methylation into fully methylated versus fully unmethylated alleles ([Fig. 5B](#F5){ref-type="fig"}). The same was true for the *Grin3b* brain gDMR ([Fig. 5B](#F5){ref-type="fig"}). We also examined methylation levels in two independent *Dnmt3a*^-/-^ *Dnmt3b*^-/-^ double KO (DKO) lines, 16aabb and 7aabb ([@R32]). These showed significant (*P*\<0.05) loss of methylation at all testis and brain gDMRs except *Crocc*, as well as at the imprinted gDMRs ([Fig. 5C,D](#F5){ref-type="fig"}). Our results confirm that, in the absence of these enzymes, methylation cannot be maintained by DNMT1 alone.

![**Enzyme dependence for gDMR classes in mouse stem cells.** (A) Methylation levels in parental J1 ESCs (WT) and DNMT1-deficient derivatives (1KO) assessed by COBRA. un, uncut control. (B) Clonal analysis of a gDMR from an imprinted, testis or brain gene (*Snrpn*, *Fkbp6* and *Grin3b*, respectively). (C) COBRA showing methylation levels in clonally derived ESCs (16aabb, 7aabb) carrying double knockouts (DKO) in both *Dnmt3a* and *Dnmt3b*. (D) Pyrosequencing for the indicated gDMRs. Blastocyst methylation levels are derived from the analysis shown in [Fig. 1D](#F1){ref-type="fig"}. Differences between DKO and WT were significant (*P*\<0.05) for all analysed genes except *Crocc*. (E) Fold reactivation in mutant versus WT cells as assessed by RT-qPCR. 3ab, DKO cells (as above); TKO, triple KO cells lacking DNMT1, DNMT3A and DNMT3B, data from Karimi et al. ([@R20]); brain and imprint gDMR unavailable. Error bars indicate s.e.m.](DEV104646F5){#F5}

Triple KO (TKO) ESCs lacking all three DNMT enzymes have been previously reported to have 4- to 15-fold increases in *Dpep3, Fkbp6, Rhox13* and *Dazl* transcript levels and ∼5-fold increases in *IAP* levels ([@R20]). We used RT-qPCR in WT, 1KO and 3ab DKO cells to separate the cell response to the loss of either the maintenance enzyme or the *de novo* enzyme systems. The greatest changes were seen at the *Dpep3* and *IAP* loci in both cell types, with greater derepression \[10-fold (*P*=0.002) and 5-fold (*P*=0.05), respectively\] in the 1KO cells ([Fig. 5E](#F5){ref-type="fig"}). The other genes, including *Fkbp6*, which showed the largest change (15-fold) in the previous study, showed smaller but reproducible (4-fold in 3ab DKO cells, *P*=0.027) alterations in transcript levels ([Fig. 5E](#F5){ref-type="fig"}). There was no significant derepression at brain gDMR genes. These results suggest that DNMT1 contributes the most to repression at these loci and that strategies aimed at inhibiting all three enzymes (such as Aza treatment) should have the greatest effect on derepression.

Non-imprinted gDMRs do not require germline passage to acquire *de novo* methylation {#S8}
------------------------------------------------------------------------------------

A number of studies have shown that imprinted gDMRs, which acquire their methylation in the growing oocyte in a *Dnmt3l*-dependent process, are unable to re-establish this methylation outside of the female germline, once lost ([@R3]; [@R13]; [@R41]; [@R46]). Since the brain and testis gDMRs also acquire their methylation in the oocyte we examined whether they too needed to pass through the germline for successful reprogramming. We examined methylation in 1KO ESCs rescued with a cDNA expressing full-length DNMT1 protein (1KO+1) ([@R30]). As expected, rescued cells fail to remethylate imprinted gDMRs ([Fig. 6A,B](#F6){ref-type="fig"}; 1KO versus IKO+1, *P*=0.57; not significant for *Peg1*); by contrast, all testis and brain gDMRs, except *Adcy6*, showed significant gains in methylation ([Fig. 6A,B](#F6){ref-type="fig"}; 1KO versus 1KO+1, *P*\<0.05).

![**Reprogramming ability of the different gDMR classes.** (A) Methylation by COBRA in ESCs with normal (WT), absent (1KO) and rescued (1KO+1) DNMT1 status. (B) Pyroassay indicates significant (*P*\<0.05) gain in methylation in 1KO+1 cells for all analysed genes except *Peg1* and *Adcy6*. (C) Overall gain in methylation in 1KO+1 cells assayed by LUMA. (D) Clonal analysis for one gene from each class of gDMR. (E) Analysis of clones indicates significant (*P*\<0.05) gain in methylation in 1KO+1 cells for all non-imprinted genes analysed. (F) Timecourse of *Dnmt1* knockdown and recovery by RT-qPCR following transient transfection of adult mouse fibroblasts with siRNA. Scr, scrambled control; d, days. (G) Pyroassay showing methylation loss and re-establishment for samples shown in F; untreated set to 100%. All genes were significantly demethylated (*P*\<0.05) at 4 days, but were no longer significantly different from untreated (UT) at 18 days, except for *Fkbp6*. (H) RT-qPCR of same samples showing re-establishment of repression. Day 4 values were set to 100%. KD, knockdown. Error bars indicate s.e.m.](DEV104646F6){#F6}

As methylation was not restored to WT levels, we quantitated the global increase in methylation in rescued cells using the LUMA assay ([@R19]), which is a bisulfite-independent quantitative assay that uses methylation-sensitive and -insensitive restriction enzyme cleavage to estimate total genomic methylation levels, and showed that 1KO+1 cells had an overall gain of 28% versus 1KO cells ([Fig. 6C](#F6){ref-type="fig"}). As the pyroassay appeared to be showing slightly lower gains in methylation than COBRA, we also carried out clonal analysis of representative genes ([Fig. 6D](#F6){ref-type="fig"}; [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.104646/-/DC1) Fig. S3). Graphing these results ([Fig. 6E](#F6){ref-type="fig"}) confirms the difference between imprinted (no significant gain, *P*=1) and non-imprinted (significant, *P*\<0.05) loci, with the average increase across the four non-imprinted gDMRs being 26%, in good agreement with LUMA ([Fig. 6C](#F6){ref-type="fig"}). In keeping with the re-establishment of repression, RT-qPCR showed that transcript levels were lower in 1KO+1 cells than in 1KO (not shown).

Levels of *de novo* methyltransferase activity in almost all adult tissues are reported to be very low ([@R31]), implying that methylation might not be restored at these non-imprinted gDMRs in adult cells. To test this, we were able to significantly deplete NIH 3T3 cells of DNMT1 using siRNA ([Fig. 6F](#F6){ref-type="fig"}; *P*=1.8×10^-5^, day 4 versus scrambled control), then allowed the DNMT1 levels to recover and examined the response of the gDMR. Four days after knockdown of DNMT1 there was a decrease in methylation at all loci tested (*P*\<0.05) due to loss of maintenance activity ([Fig. 6G](#F6){ref-type="fig"}; untreated levels set to 100%), with brain gDMRs showing the greatest response. As DNMT1 levels recovered the percentage of methylated sites increased, presumably due to its maintenance activity stabilising the methylation added by the *de novo* enzymes, as in ESCs \[see above and Oda et al. ([@R30])\], until by 18 days there was no longer a significant difference (all *P*\>0.05) in methylation between untreated and treated cells except at the *Fkbp6* locus, which remained demethylated (*P*\<0.007). Examination of transcription levels showed that, following derepression (*P*\<0.05) of testis gDMR genes at day 4 (subsequently set to 100%), the genes were silenced again rapidly ([Fig. 6H](#F6){ref-type="fig"}).

DISCUSSION {#S9}
==========

Although a number of recent studies have identified transient gDMRs methylated in the oocyte ([@R2]; [@R21]; [@R33]; [@R39]; [@R40]), the functional significance of the methylation and the types of genes affected were not identified. We show here for the first time that transient gDMRs fall into two classes, one containing genes predominantly expressed in the testis and the other enriched in genes associated with brain function. Both groups have higher levels of methylation in the oocyte than in sperm, are very dependent on DNMT3L and retain methylation at levels of 25% or more in blastocyst ([Fig. 7](#F7){ref-type="fig"}). Although they resemble imprinted genes in these respects, they fail to maintain differential methylation in differentiated somatic tissues due to *de novo* methylation of paternal alleles after implantation. As previously noted ([@R39]; [@R33]), this highlights protection of the unmethylated imprinted allele in the post-gastrulation embryo as one of the most important properties of imprinted loci.

![**Methylation dynamics and methyltransferase dependency of genes inheriting methylation from the mother.** (Top) Methylation ontogeny of brain, testis and imprinted gDMRs, as well as of postimplantation genes. The average methylation of each gene class (see key, bottom right) is shown: filled bar, 100% methylation; empty bar, 0% methylation. Methyltransferase requirements at different stages, where established, are shown within the central blue panel. (Bottom) The effect of loss and restoration of methyltransferase activity in different experimental systems. The dish on the right represents ESCs.](DEV104646F7){#F7}

The difference between a transient gDMR described here and an imprinted gDMR at a gene such as *Cdh15* is not substantial, as the latter gains methylation postimplantation on the paternal allele as well as becoming biallelically expressed in certain tissues ([@R33]). It has been previously noted that many imprinted genes are expressed in brain ([@R47]) and have intragenic gDMRs ([@R38]). Since slightly more than half of all transient gDMRs are associated with brain ontologies ([Fig. 1B](#F1){ref-type="fig"}) and are at CGIs old enough to show conservation between human and mouse ([Fig. 4](#F4){ref-type="fig"}), it seems reasonable to speculate that some brain-specific imprinted genes might have arisen from this particular group by, for example, alterations at a transient gDMR locus that allow for protection of the paternal allele from *de novo* methylation postimplantation.

With respect to the functional significance of methylation at the transient gDMR, we show that demethylation causes transcriptional derepression of testis genes in the *Dnmt3l^-/-^* ovary, *Dnmt1^-/-^* or *Dnmt3ab^-/-^* stem cells, and Aza-treated or *DNMT1* siRNA-treated adult cells, with the effect being much greater in the differentiated somatic cells. It is possible that methylation of the maternal allele is used to effectively halve the expression level of the transient gDMR preimplantation: however, this effect is likely to be small at this developmental stage, as derepression in KO ESCs is orders of magnitude lower than in differentiated cells. Testis genes that are regulated by a gDMR can be identified by the following characteristics: they have a high density or 'strong' CGI at the promoter, they are \>75% methylated in oocytes, are DNMT3L dependent and retain methylation above 25% in blastocyst. Interestingly, although it has been suggested that intermediate density or 'weak' CGIs would be most susceptible to regulation by methylation ([@R2]; [@R45]) we found that loss of methylation at weak CGIs could not derepress most of the genes examined: many of the loci identified by meDIP fall into this category.

Significantly, there is good conservation in humans of the CGIs that represent the gDMRs for both the testis and brain genes and they are also heavily methylated in adult tissues, which is atypical for most CGIs ([@R2]). Conservation points to an evolutionarily conserved requirement for methylation at these loci: this is consistent with a regulatory role for the testis group, as they can be derepressed following demethylation, as in mouse.

We also show that demethylation of genes in the postimplantation group causes their transcriptional derepression in human fibroblasts, which is the first demonstration, to the best of our knowledge, of this in a normal human cell type. Likewise, we are not aware of any previous report showing restoration of methylation at endogenous single-copy sequences (as opposed to retroviral genes) by *de novo* activity in an adult differentiated cell type. All of the genes examined were more refractory to demethylation and activation in the hTERT-1604 human fibroblasts than in the mouse NIH 3T3 fibroblasts, most likely because the latter, older cell line has become more responsive to culture conditions over time. Greater transcriptional response was seen to Aza, which inhibits all three methyltransferases, than for *DNMT1* siRNA alone, which might reflect some dependence on DNMT3A/B for maintenance in these cells as in mouse ESCs. Genes methylated postimplantation, such as *SYCP3*, lost their methylation more readily and were reactivated to a greater extent in the human cells than the testis gDMR homologues, such as *FKBP6*, which might reflect underlying differences in chromatin state between the two gene classes.

Although intragenic methylation has been reported previously for some brain genes ([@R24]; [@R27]; [@R49]), this is the first report, to our knowledge, to show that neuronal genes represent the major class that inherits methylation from the mother, with possible implications for transmission of neuronal phenotypes. Notably, methylation at these loci is at intragenic 'orphan' CGIs identified by CFP1 pulldown ([@R17]; [@R39]). It has been suggested that orphan CGIs can act as promoters early during development, becoming inactivated and methylated later ([@R17]). However, for the particular subset of orphan CGIs identified here as carrying gametic marks, 82% show no evidence of being transcriptional start sites in ESCs, this fraction rising to 89% in adult brain ([Fig. 1F](#F1){ref-type="fig"}). Consistent with this, their demethylation resulted in no marked upregulation in steady-state mRNA levels. Recent reports suggest that intragenic methylation in somatic tissues, particularly at neuronal genes, might instead play a role in maintaining active chromatin states ([@R49]) or in splice choice ([@R28]). Preliminary analysis shows that this class of genes is indeed significantly enriched for alternative splicing using the DAVID ontology tool SP_PIR_KEY (46% of brain genes from the RRBS dataset, *P=*2.4×10^-13^, FDR=3.0×10^-10^). Further investigation of our brain gDMR set seems warranted given the conservation of both positioning and methylation status for the promoter and intragenic CGIs of the brain genes in human.

In addition to DNMT1 ([@R12]; [@R14]), ZFP57, a zinc finger-containing transcription factor, is also vital for methylation maintenance at all imprinted loci and some non-imprinted loci in preimplantation embryos and ESCs. Interestingly, *Fkbp6*, which is a testis gDMR, was also bound by ZFP57 and showed loss of methylation in KO cells ([@R34]). When we analysed the sites bound by ZFP57 in genome-wide ChIP studies we failed to uncover any other non-imprinted gDMRs from our study, suggesting that other factors might be involved in maintaining methylation at the other gDMR classes. Notably, *Fkbp6* regained most methylation in 1KO+1 rescued ESCs, which express ZFP57: at the same time, it was refractive to remethylation in adult mouse and human fibroblasts, which are predicted to lack this factor. At the testis gDMR loci generally, recovery of methylation was coincident with re-establishment of transcriptional repression. These results also have important implications for the response of cells to demethylating agents.

In conclusion, we have identified two new classes of functionally significant gDMRs that appear to be evolutionarily conserved and might be important mediators of the phenotypic effects of pre- and postnatal environmental exposures that alter DNA methylation levels.

MATERIALS AND METHODS {#S10}
=====================

Bioinformatic analysis and statistics {#S11}
-------------------------------------

Published genome-wide methylation data from a number of studies ([@R2]; [@R21]; [@R39]) were re-examined using publicly available tools. Ontology analysis including statistical significance was performed in DAVID ([@R16]). Transcription marks associated with orphan CGIs were derived from Illingworth et al. ([@R17]). Comparison of gene features was carried out in GALAXY ([@R7]).

All laboratory experiments were carried out in triplicate, including at least one biological repeat: graphs show a representative experiment, and error bars represent s.e.m. Statistical analysis of results was carried out in Prism (GraphPad) or Excel (Microsoft): pyrosequencing results were compared by ANOVA, RT-qPCR results were analysed by *t*-test and bisulfite clonal analysis results were compared by χ^2^ test.

Mouse strains {#S12}
-------------

Derivation of *Dnmt3l* knockout oocytes/ovaries and matched WT tissues was as previously described ([@R18]). All other mouse tissues were derived from outbred TO mice (Harlan, Huntingdon, UK). Animal work was carried out under licence from the appropriate regulatory bodies.

Cells {#S13}
-----

Culture media components are from Invitrogen unless otherwise stated. NIH 3T3 and hTERT-1604 fibroblasts were cultured in 4.5 g/l glucose D-MEM supplemented with 10% FBS and 2× NEAA. *Dnmt1* KO (± *Dnmt1*), *Dnmt3a/3b* DKO ESCs and matched WT J1 cells were a kind gift of Dr M. Okano (RIKEN Center for Developmental Biology, Kobe, Japan). ESCs were maintained on Nunc plates (Davidson & Hardy, Belfast, UK) treated with 0.1% gelatin (Sigma-Aldrich) and cultured in KnockOut D-MEM plus 15% KnockOut Serum Replacement, 1% ESC qualified FBS, 1× NEAA, 2 mM [l]{.smallcaps}-glutamine, 0.1 mM β-mercaptoethanol (Sigma-Aldrich) and 1000 U/ml LIF (Chemicon). For treatment with 5-aza-2′-deoxycytidine (Aza), 8×10^4^ NIH 3T3 cells or 1×10^5^ hTERT-1604 cells were seeded onto a 90 mm plate in complete medium and allowed to attach overnight before replacing with complete medium containing 1 μM Aza, which was renewed at 24-hour intervals up to 72 hours.

siRNA treatment {#S14}
---------------

siRNA treatments were carried out in 6-well plates, each well seeded with 1×10^6^ hTERT-1604 cells or 1×10^5^ NIH 3T3 cells, before reverse transfection using Dharmafect 1 (Thermo Fisher Scientific) and 80 nM (NIH 3T3) or 100 nM (hTERT-1604) ON-TARGETplus SMARTpool *DNMT1* siRNA or a matched concentration of scrambled control (Thermo Fisher Scientific). Cells were cultured in complete medium to allow recovery, with extraction of RNA and DNA up to 28 days after addition of siRNA.

*In situ* hybridisation {#S15}
-----------------------

*In situ* hybridisation was performed as previously described ([@R37]). Primers used to generate probes are listed in [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.104646/-/DC1) Table S1.

Bisulfite treatment {#S16}
-------------------

Oocyte and sperm collection and isolation of DNA were as described ([@R23]; [@R42]). DNA was extracted from NIH 3T3 and hTERT-1604 cells using the Genomic DNA Purification Kit (Fermentas). All other non-germ cell samples were incubated overnight at 55°C in lysis buffer (50 mM Tris pH 8, 0.1 M EDTA, 0.5% SDS, 0.2 mg/ml proteinase K) with rotation, and DNA was subsequently isolated by standard phenol:chloroform extraction. Total DNA from 150-200 oocytes or 200-500 ng DNA from other samples was bisulfite converted using the EpiTect Bisulfite Kit (Qiagen).

Methylation analysis {#S17}
--------------------

Bisulfite-treated DNA was PCR amplified in 1× buffer, 0.4 mM dNTPs, 1 μM primers ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.104646/-/DC1) Table S1), MgCl~2~ at a concentration specific to the primer set and 0.01 U Taq DNA polymerase (reagents from Invitrogen). Nested PCRs and COBRA were carried out as previously described ([@R23]) using *Bst*UI (*Dazl, Dpep3, Piwil1* and *Snrpn*) or *Taq*^α^I (*Csnka2ip, Fkbp6, H19, Rhox13* and *Sycp3*) enzymes from NEB. Bisulfite sequencing of cloned PCR products in pCRII-TOPO vector (Invitrogen) was performed using the ABI PRISM 3130 Genetic Analyzer (Applied Biosystems). Pyrosequencing assays are from Qiagen ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.104646/-/DC1) Table S2), except murine *Adcy6, Crocc* and *Fkbp6* and human *EFNA* and *GRIN3B*, which were all designed in house using PyroMark Assay Design software 2.0 ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.104646/-/DC1) Table S1). Assays were conducted using the PyroMark PCR Kit (Qiagen); conditions were: 95°C, 15 minutes; followed by 45 cycles of 94°C for 30 seconds, 56°C for 30 seconds and 72°C for 30 seconds; with final elongation at 72°C, 10 minutes. LUMA analysis was carried out as previously described ([@R19]).

RNA extraction and RT-PCR {#S18}
-------------------------

RNA from all samples was extracted using the RNeasy Mini Kit (Qiagen). Reverse transcription reactions contained 300-500 ng total RNA, 0.5 μM dNTPs, 0.5 μg oligo(dT) primer, 40 U RNaseOUT (Invitrogen), 1× reverse transcriptase buffer (Fermentas) and 200 U RevertAid reverse transcriptase (Fermentas) in a total volume of 20 μl. Reaction conditions were: 42°C, 50 minutes; 70°C, 15 minutes. cDNA was stored at -20°C until use.

Each RT-PCR contained 1× buffer, 0.4 mM dNTPs, 1 μM primers ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.104646/-/DC1) Table S1), MgCl~2~ at a concentration specific to the primer set and 0.01 U Taq DNA polymerase. The general PCR format was: 94°C, 3 minutes; followed by cycles of 94°C for 30 seconds, gene-specific annealing temperature for 1 minute and 72°C for 1 minute; with final elongation at 72°C, 5 minutes. RT-qPCRs were performed using 1× LightCycler 480 SYBR Green I Master (Roche), 0.5 μM primers and 1 μl cDNA. Reactions were run on the LightCycler 480 II (Roche), with an initial incubation step of 95°C, 10 minutes; followed by 50 cycles of 95°C for 10 seconds, 60°C for 10 seconds and 72°C for 10 seconds. Expression was normalised to *Hprt*, and relative expression was determined using the ΔΔC~T~ method.

Supplementary Material
======================
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